Atlas Venture Life Science Advisors LLC disclosed a new position in Kailera Therapeutics, Inc. via a recent 13F filing. The firm acquired 5,171,282 shares during the second quarter.
The investment is valued at approximately $113,923,000. This purchase gives Atlas Venture a 3.99% ownership stake in the biotechnology company.
The holding represents 12.9% of the investor's total portfolio. It now ranks as the firm's fourth-largest position.